The Macfarlane Trust (MFT) was set up in 1988 by the British Government to support people with haemophilia who were infected with HIV as a result of contaminated NHS blood products, and their spouses, parents, children and dependants. During the late 1970s and early 1980s more than 1,200 people with haemophilia were infected with HIV through their clotting factor treatment. A large proportion of people were also infected with Hepatitis C.
MFT currently receives approximately £2.2 million each year from the Department of Health. The majority of this funding is spent on discretionary regular payments to those who were infected ("primary beneficiaries") and to bereaved spouses/partners. There is also a small annual grants budget, and MFT is also able to refer beneficiaries for specialist benefits and money management/debt advice.
Department of Health Consultation - Infected blood: reform of financial and other support
On 21 January 2016, the Under Secretary of State for Public Health, Jane Ellison MP, announced the launch of a consultation on reform of the existing financial and other support to those infected with HIV and Hepatitis C as a result of contaminated blood. You can read and download a copy of the document from the Department of Health website here.
On 28 January 2016 we wrote to all MFT beneficiaries summarising the proposals in the consultation, and outlining our understanding of how the proposed changes will affect the financial and other support MFT beneficiaries receive if the proposals go ahead. You can read and download a copy of the letter here and a copy of the summary here.
The consultation on the proposed changes closes on 15 April 2016. We would encourage all beneficiaries to respond to the document, whether you support the proposals or oppose them, so that the Government hears from as many people as possible.